VR Logo

Dishman Pharmaceuticals & Chemicals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1983

Chairman: Janmejay R Vyas

Managing Director: Arpit J Vyas

Group: Dishman Pharma

Listing:

Headquarters: --

Website:--

Key Facts

Market cap: R --

Revenue (TTM): R --

Earnings (TTM): R --

: R --

: R --

Promoters' ownership: --

Liquidity:

52 Week range: R -- - --

Face value: R--

Shares outstanding: --

10 Years Aggregate:

  • CFO: 1,921.71 Cr
  • EBITDA: 2,503.24 Cr
  • Net Profit: 1,115.59 Cr

Stock Performance

Time Period Dishman Pharma & Chem S&P BSE Healthcare S&P BSE Mid Cap
YTD--46.230.06
1 month--1.335.18
3 months--14.398.65
1 Year--52.694.03
3 Years--11.80-2.48
5 Years--1.476.09
10 Years--11.715.91
As on 23-Oct-2020
Year Dishman Pharma & Chem S&P BSE Mid Cap S&P BSE Healthcare
201628.267.97-12.88
2015147.637.4315.06
201430.3054.6947.43
2013-13.96-5.7322.55
2012208.1938.2738.28
2011-76.28-34.19-12.83
2010-33.9816.1534.19